Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-22-023524

President and CEO acquired 111,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SCANGOS GEORGE A · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-10 Grant or award : show line 1 in the form +111,000 223,989 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-10 Grant or award : show line 2 in the form Stock Option (Right to Buy) +222,000 222,000 D
Loading xslF345X03/doc4.xml…